-
Why Neumora Therapeutics Analysts Are Bullish About Major Depressive Disorder Drug
Tuesday, October 10, 2023 - 10:55am | 378Shares of Neumora Therapeutics Inc (NASDAQ: NMRA) were trading lower on Tuesday, a month after the company announced its IPO on the NASDAQ exchange. RBC Capital Markets On Neumora Therapeutics Analyst Brian Abrahams initiated coverage with an Outperform rating and price target of $24. Neumora...